Sign up United Kingdom
Proactive Investors - Run By Investors For Investors

Proactive news snapshot: Advanced Oncotherapy, Wishbone Gold, Brave Bison Group ….

A glance at some of the day's highlights from the Proactive Investors newswire
Your daily round-up from the world of Proactive

Advanced Oncotherapy PLC (LON:AVO), the developer of next-generation proton therapy systems for cancer treatment, has secured £37.4mln of financing with £30mln of this coming from a new Chinese investor. The injection will bankroll the continuing technical development of the firm’s first LIGHT system and its installation at the Harley Street Proton Therapy Centre.

Wishbone Gold PLC (LON:WSBN) said its operations in Honduras are getting back in the swing of things now the wet season is over. The weather has now improved and the buildings are expected to be completed in the next couple of weeks, wishbone said.

Investors in Brave Bison Group PLC (AIM: BBSN), the digital media and social video specialist, will be heartened by the news its net revenues for the year will come in ahead of forecast at around £9.1mln. “The group continues to move up the value chain, with an increased focus on production and branded content deals, resulting in higher-margin revenues,” it said in a trading update.

The number of active customers at S & U Plc’s (LON:SUS) motor finance arm continues to grow at a fair old lick. Advantage Finance, S & U's specialist motor finance provider, has seen active customer numbers rise from 49,000 at the end of July to 53,000, while net customer receivables have risen above £240mln for the first time – up from nearly £227mln in July.

Echo Energy Plc (LON:ECHO) has said progress continues to be made in advancing preparations for its proposed Argentinian farm-in deal, announced on November 1, with documentation at an advanced stage and there has been an extension to the closing date.

Savannah Resources Plc (LON:SAV) said its consortium with wholly-owned subsidiary AME East Africa and Rio Tinto PLC (LON:RIO) has completed the commissioning of a pilot processing plant at the Mutamba Mineral Sands project in Mozambique.

Fox Marble PLC (LON:FOX) has taken out an unsecured £500,000 loan with non-executive director Roy Harrison so it can invest in expanding its production facilities.

HemoGenyx Pharmaceuticals PLC (LON:HEMO) is making good progress in the laboratory on its two pioneering new treatments for blood cancer sufferers, it told shareholders at its annual meeting. The biotech, which listed on AIM in October, is developing two therapies to improve the chances of survival of people requiring a bone marrow transplant.

Hurricane Energy PLC (LON:HUR) told investors it has now hired executive search recruiter Spencer Stuart to source the company’s new chairman. The UK offshore oil company said in a statement that once a new chairman is in place it will seek to appoint additional independent non-executive directors to the board in order to make it fully compliant with corporate governance guidelines.

88 Energy Ltd’s (LON:88E) well programme may be on winter layover, but, that doesn’t mean the group’s interest in its Alaskan shale project has cooled – today, the oil and gas junior confirmed it is expanding its footprint. Named as the high bidder for two parcels of land, spanning a combined 32,800 gross acres, the explorer’s base has increased in Alaska’s North Slope region.

Ariana Resources plc (LON:AAU) has announced its latest new gold discovery at the Salinbas project, in Turkey. The exploration company told investors it has unearthed a significant anomaly, a 500x150 metre zone of precious metal and base metal, in the Salinbas North area.

Metal Tiger PLC (LON:MTR) said initial results from a mining study of the T3 copper project in Botswana have been “encouraging”. The company said the study of the joint venture project with MOD Resources Limited supports the start of a 30-hole resource drilling programme targeting high-grade veins with underground mining potential. In a separate statement, the company said it had received a final report from a Groundwater Research Institute report, at the Khon Kaen University in Thailand, in relation to the Song Toh and Boh Yai lead-zinc-silver projects.

Macarthur Minerals Limited (CVE:MMS) has signed a strategic alliance with 3PL Operating to explore its Reynolds Springs lithium brine prospect in Nevada’s Railroad Valley. Cadence Minerals Plc (LON:KNDC) owns a 15.2% stake in Macarthur.

Stratex International plc (LON:STI) has said its investee company, Thani Stratex Resources, might need to make a few tweaks to the maiden resource estimate it published on Wednesday for the Anbat gold project in Egypt.

Xtract Resources PLC’s (LON:XTR) Mozambican subsidiary Explorator Limitada has negotiated a “significantly enhanced” deal with the contract alluvial miners at the Manica gold project.

Be Heard PLC (LON:BHRD) has announced that Ian Maude, its group development director, has indicated his intention to step down from the executive team and board in March 2018 to relocate to Sweden where his partner is based. The digital marketing services group said Maude will oversee an orderly handover to Richard Costa D'Sa, currently Be Heard’s chief growth officer, who will assume the responsibilities of group development director.

Stobart Group Limited (LON:STOB)  said dividends of 4.5p per share were paid on 6 October 2017 and the board has now declared a further interim dividend of 4.5p per share which will be paid on 19 January 2018 to shareholders on the register as at 22 December 2017. It added that, subject to board approval, further quarterly dividend payments of 4.5p per share will be made on 13 April 2018.

No investment advice

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

© Proactive Investors 2018

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use